S. Galgani

909 total citations
15 papers, 533 citations indexed

About

S. Galgani is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, S. Galgani has authored 15 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 6 papers in Immunology and 5 papers in Neurology. Recurrent topics in S. Galgani's work include Multiple Sclerosis Research Studies (7 papers), T-cell and B-cell Immunology (6 papers) and Peripheral Neuropathies and Disorders (5 papers). S. Galgani is often cited by papers focused on Multiple Sclerosis Research Studies (7 papers), T-cell and B-cell Immunology (6 papers) and Peripheral Neuropathies and Disorders (5 papers). S. Galgani collaborates with scholars based in Italy, United States and United Kingdom. S. Galgani's co-authors include Claudio Gasperini, Luca Battistini, Giovanna Borsellino, Carlo Pozzilli, Alessandro Poggi, Maria Raffaella Zocchi, Elisabetta Ferrero, Roberta Placido, Giovanni Ristori and Celia F. Brosnan and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Neurology.

In The Last Decade

S. Galgani

15 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Galgani Italy 12 226 213 120 120 97 15 533
Noelia Villarrubia Spain 11 352 1.6× 181 0.8× 135 1.1× 140 1.2× 99 1.0× 29 525
Liza Rijvers Netherlands 10 162 0.7× 200 0.9× 70 0.6× 49 0.4× 25 0.3× 13 461
Manuel San United States 5 147 0.7× 257 1.2× 46 0.4× 36 0.3× 53 0.5× 6 385
René M. Gieß Germany 11 224 1.0× 74 0.3× 85 0.7× 73 0.6× 69 0.7× 16 333
Giulia Contessa Italy 6 265 1.2× 287 1.3× 66 0.6× 45 0.4× 57 0.6× 12 465
Christopher LaGanke United States 9 193 0.9× 66 0.3× 44 0.4× 80 0.7× 65 0.7× 28 287
Sunny Malhotra Spain 12 108 0.5× 211 1.0× 257 2.1× 34 0.3× 38 0.4× 26 484
David D. Hebrink United States 13 207 0.9× 264 1.2× 144 1.2× 38 0.3× 103 1.1× 16 495
Raffaele Murru Italy 11 183 0.8× 125 0.6× 83 0.7× 29 0.2× 77 0.8× 23 368
Martina Kunkl Italy 11 95 0.4× 183 0.9× 110 0.9× 23 0.2× 24 0.2× 16 406

Countries citing papers authored by S. Galgani

Since Specialization
Citations

This map shows the geographic impact of S. Galgani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Galgani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Galgani more than expected).

Fields of papers citing papers by S. Galgani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Galgani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Galgani. The network helps show where S. Galgani may publish in the future.

Co-authorship network of co-authors of S. Galgani

This figure shows the co-authorship network connecting the top 25 collaborators of S. Galgani. A scholar is included among the top collaborators of S. Galgani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Galgani. S. Galgani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Petrone, Linda, Carla Tortorella, Alessandra Aiello, et al.. (2022). Humoral and Cellular Response to Spike of Delta SARS-CoV-2 Variant in Vaccinated Patients With Multiple Sclerosis. Frontiers in Neurology. 13. 881988–881988. 18 indexed citations
2.
Libera, Dacia Dalla, Diletta Di Mitri, Alessandra Bergami, et al.. (2011). T Regulatory Cells Are Markers of Disease Activity in Multiple Sclerosis Patients. PLoS ONE. 6(6). e21386–e21386. 62 indexed citations
3.
4.
Pozzilli, Carlo, Giovanni Antonini, Francesca Bagnato, et al.. (2002). Monthly corticosteroids decrease neutralizing antibodies to IFNβ1b: a randomized trial in multiple sclerosis. Journal of Neurology. 249(1). 50–56. 63 indexed citations
5.
Paolillo, Andrea, Carlo Pozzilli, Elisabetta Giugni, et al.. (2002). A 6‐year clinical and MRI follow‐up study of patients with relapsing–remitting multiple sclerosis treated with Interferon‐beta. European Journal of Neurology. 9(6). 645–655. 57 indexed citations
6.
Borsellino, Giovanna, Omanand Koul, Roberta Placido, et al.. (2000). Evidence for a role of γδ T cells in demyelinating diseases as determined by activation states and responses to lipid antigens. Journal of Neuroimmunology. 107(2). 124–129. 15 indexed citations
7.
Borsellino, Giovanna, Fabrizio Poccia, Roberta Placido, et al.. (2000). Phenotypic and functional properties of γδ T Cells from patients with Guillain Barré syndrome. Journal of Neuroimmunology. 102(2). 199–207. 14 indexed citations
8.
Poggi, Alessandro, Maria Raffaella Zocchi, Paola Costa, et al.. (1999). IL-12-Mediated NKRP1A Up-Regulation and Consequent Enhancement of Endothelial Transmigration of Vδ2+ TCRγδ+ T Lymphocytes from Healthy Donors and Multiple Sclerosis Patients. The Journal of Immunology. 162(7). 4349–4354. 52 indexed citations
9.
Poggi, Alessandro, Maria Raffaella Zocchi, Paola Costa, et al.. (1999). IL-12-mediated NKRP1A up-regulation and consequent enhancement of endothelial transmigration of V delta 2+ TCR gamma delta+ T lymphocytes from healthy donors and multiple sclerosis patients.. PubMed. 162(7). 4349–54. 63 indexed citations
10.
Gasperini, Claudio, Carlo Pozzilli, Stefano Bastianello, et al.. (1998). Effect of steroids on Gd‐enhancing lesions before and during recombinant beta interferon la treatment in relapsing remitting multiple sclerosis. Neurology. 50(2). 403–406. 35 indexed citations
11.
Koudriavtseva, Tatiana, Carlo Pozzilli, Marco Fiorelli, et al.. (1998). Determinants of Gd-enhanced MRI response to IFN-β-1a treatment in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal. 4(5). 403–407. 9 indexed citations
12.
Gasperini, Claudio, Carlo Pozzilli, Stefano Bastianello, et al.. (1997). The influence of clinical relapses and steroid therapy on the development of Gd-enhancing lesions: a longitudinal MRI study in relapsing-remitting multiple sclerosis patients. Acta Neurologica Scandinavica. 95(4). 201–207. 16 indexed citations
13.
Fieschi, C., Carlo Pozzilli, Stefano Bastianello, et al.. (1995). Human recombinant interferon beta in the treatment of relapsing-remitting multiple sclerosis: preliminary observations. Multiple Sclerosis Journal. 1(1_suppl). S28–S31. 4 indexed citations
14.
Pocchiari, Maurizio, Mirella Salvatore, Francesca Cutruzzolà, et al.. (1993). A new point mutation of the prion protein gene in Creutzfeldt‐Jakob disease. Annals of Neurology. 34(6). 802–807. 84 indexed citations
15.
Galgani, S., et al.. (1983). Acute hypokalemic myopathy due to chronic licorice ingestion: report of a case. Neurological Sciences. 4(4). 493–497. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026